Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
39
AKBA Quote, Financials, Valuation and Earnings
Last price:
$1.84
Seasonality move
:
7.91%
Day range:
$1.75 - $1.87
52-week range:
$0.80 - $2.48
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.20x
P/B ratio:
--
Volume:
5.9M
Avg. volume:
2.2M
1-year change:
52.92%
Market cap:
$400.4M
Revenue:
$194.6M
EPS (TTM):
-$0.23
Earnings Data
Next earnings date for AKBA
Mar 14
2025
Most recent earnings per share
-$0.10
Missed by $0.05
(Nov 7/2024)
Consensus Estimate
-$0.05
(Nov 7/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
AKBA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/14/2025 | Q4 | $40.9M | -- | -- | -$0.04 | -- |
| 11/07/2024 | Q3 | $44.5M | $37.4M | -$0.10 | -$0.05 | -$0.05 |
| 08/08/2024 | Q2 | $43.7M | $43.6M | -$0.04 | -$0.05 | $0.01 |
| 05/09/2024 | Q1 | $46.1M | $32.6M | -$0.09 | -$0.09 | -- |
| 03/14/2024 | Q4 | $55.4M | $56.2M | $0.00 | -$0.05 | $0.05 |
| 11/08/2023 | Q3 | -- | -- | -$0.08 | -$0.09 | $0.01 |
| 08/25/2023 | Q2 | -- | -- | -$0.06 | -$0.03 | -$0.04 |
| 05/08/2023 | Q1 | -- | -- | -$0.14 | -$0.15 | $0.01 |
| 03/09/2023 | Q4 | -- | -- | -$0.04 | -$0.16 | $0.12 |
| 11/03/2022 | Q3 | -- | -- | -$0.28 | -$0.12 | -$0.16 |
| 08/04/2022 | Q2 | -- | -- | $0.15 | -$0.33 | $0.48 |
| 05/09/2022 | Q1 | -- | -- | -$0.35 | -$0.29 | -$0.06 |
| 03/01/2022 | Q4 | -- | -- | -$0.40 | -$0.30 | -$0.11 |
| 11/04/2021 | Q3 | -- | -- | -$0.34 | -$0.29 | -$0.05 |
| 08/05/2021 | Q2 | -- | -- | -$0.51 | -$0.31 | -$0.20 |
| 05/10/2021 | Q1 | -- | -- | -$0.45 | -$0.36 | -$0.09 |
| 02/25/2021 | Q4 | -- | -- | -$0.60 | -$0.42 | -$0.18 |
| 11/05/2020 | Q3 | -- | -- | -$0.42 | -$0.24 | -$0.18 |
| 08/10/2020 | Q2 | -- | -- | -$1.28 | -$0.47 | -$0.81 |
| 05/05/2020 | Q1 | -- | -- | -$0.47 | -$0.60 | $0.13 |
| 03/10/2020 | Q4 | -- | -- | -$0.79 | -$0.47 | -$0.32 |
| 11/12/2019 | Q3 | -- | -- | -$0.46 | -$0.41 | -$0.05 |
| 08/08/2019 | Q2 | -- | -- | -$0.49 | -$0.36 | -$0.14 |
| 05/09/2019 | Q1 | -- | -- | -$0.62 | -$0.36 | -$0.26 |
| 03/18/2019 | Q4 | -- | -- | -$0.93 | -$0.38 | -$0.55 |
| 11/08/2018 | Q3 | -- | -- | -$0.46 | -$0.56 | $0.10 |
| 08/08/2018 | Q2 | -- | -- | -$0.60 | -$0.42 | -$0.18 |
| 05/09/2018 | Q1 | -- | -- | -$0.48 | -$0.53 | $0.05 |
| 03/12/2018 | Q4 | -- | -- | $0.25 | -$0.44 | $0.69 |
| 11/08/2017 | Q3 | -- | -- | -$0.49 | -$0.46 | -$0.03 |
| 08/08/2017 | Q2 | -- | -- | -$0.53 | -$0.92 | $0.39 |
| 05/09/2017 | Q1 | -- | -- | -$1.15 | -$0.41 | -$0.74 |
| 03/06/2017 | Q4 | -- | -- | -- | $2.13 | -- |
| 11/09/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/08/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/09/2016 | Q1 | -- | -- | -- | -- | -- |
| 03/14/2016 | Q4 | -- | -- | -- | -- | -- |
| 11/09/2015 | Q3 | -- | -- | -- | -- | -- |
| 08/10/2015 | Q2 | -- | -- | -- | -- | -- |
| 05/11/2015 | Q1 | -- | -- | -- | -- | -- |
| 03/09/2015 | Q4 | -- | -- | -- | -- | -- |
Akebia Therapeutics Earnings Questions
-
How Much did Akebia Therapeutics Generate in Revenue Last Quarter?
Akebia Therapeutics reported $37.4M worth of top line sales in its most recent quarter.
-
Did Akebia Therapeutics Beat Earnings Last Quarter?
Akebia Therapeutics announced earnings per share of -$0.10 which represents a miss of analyst forecast a -$0.05 per share.
-
Is Akebia Therapeutics Profitable?
Akebia Therapeutics reported $23.3M that represents $0.11 per share over the last quarter.
-
What is the Analyst Consensus for Akebia Therapeutics EPS Next Year?
Akebia Therapeutics's earnings are forecast to decrease from -$0.28 per share to -$0.34 per share next year representing a decrease of -7.14%.
-
When is Akebia Therapeutics's Earnings Date?
Akebia Therapeutics's next earnings date is March 14, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
